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Abstract: Internationally recognized Spanish experts in the food industry, nutrition, toxicology,
sustainability, and veterinary science met in Madrid on July 2018 to develop a consensus about palm
oil (PO) as a food ingredient. Their aim was to provide a useful, evidence-based point of reference
about PO. Scientific evidence about the role of PO in food safety, nutrition and sustainability was
analyzed. Main conclusions were: (1) RSPO foundation responded to the environmental impact
of palm crops. The Amsterdam Declaration pursues the use of 100% sustainable PO in Europe
by 2020. Awareness about choosing sustainable products will help to maintain local economies
and environments in the producing countries; (2) evidence shows that a moderate intake of PO
within a healthy diet presents no risks for health. No evidence justifies any change fat intake
recommendations; (3) food industry is interested in assuring safe, sustainable and high-quality
products. The use of certified sustainable PO is increasing; and (4) there is no evidence associating
PO consumption and higher cancer risk, incidence or mortality in humans. Tolerable daily intake
(TDI) for toxic contaminants (2-and 3-monochloropropanediols (MCPDs), glycidyl esters (GEs)) have
been established by JECFA and EFSA. Consequently, the European Commission has modified the
Contaminants Regulation for GEs and it is still working on 3-MCPDs’.
Keywords: palm oil; sustainability; 3MCPD; palmitic acid; cardiovascular disease; food industry;
communication
1. Introduction: Justification and Need of the Consensus
Oil palm has been cultivated for more than 5000 years. Palm oil is the most commonly used
vegetable oil in the world today [1]. Palm fruit oil, generally known as palm oil, is produced from
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the pulp of the fruit of the oil palm (Elaeis guineensis) [2]. This tropical fruit is reddish due to its high
β-carotene content. The fruit is between 3 and 5 cm long and has a single seed or walnut, which is
used to produce palm nut oil, also called palm kernel oil [3]. Each palm fruit contains in total around
30%–35% of oil. The legal denomination of this product in Spain according to Royal Decree 1011/1981
of 10 April approving the Technical sanitary regulation for the elaboration, circulation and trade of
edible fats (animal, vegetable and anhydrous), margarines, minarines and fatty preparations [4] is
“palm butter”; however, we use the terms “palm oil” or “palm fat” throughout this document, as the
names used most often in Spain and at international level.
Palm oil and palm kernel oil have the same botanical origin, but differ significantly in their fatty
acid (FA) composition. According to the United States Department of Agriculture (USDA), in 2017/18
growth of world palm oil production closed at 7% above the previous year, rising from 65.25 million tons
(Mt) in the year 2016/17 to about 70 Mt in 2017/18, the main producers being Malaysia and Indonesia.
Of total world production, 5% is used for biofuels, 24% for cosmetics, and 71% by the food industry. For
its part, in the European Union (EU), 87% of imports went to the manufacture of biodiesel. In the year
2000, the EU consumed a bare 271,000 metric tons of palm oil, rising to 3.9 Mt in 2017, with an average
annual increase of 7%. The last year saw a downward trend in imports and consumption in the EU,
especially palm oil for food and household use, while palm oil for industrial use remained stable [1].
In the food industry, palm oil is used primarily to replace animal fats and hydrogenated fats. Be it
remembered that as a result of the research conducted by Keys in the Seven Countries Study [5], and
others [6], the intake of saturated animal fats was associated with increased cardiovascular risk (CVR).
In view of these findings, during the 1990s animal fats (lard, butter) began to be replaced by others. In
these years, the hydrogenation of oils for margarine was seen by the industry as a good solution for
obtaining solid or semi-solid fats with a variety of possibilities for melting/crystallization dynamics
and for melting temperatures. Between 2000 and 2010, there was growing awareness of the negative
effects of trans-FAs on cardiovascular health, also associated with increased risk of atherosclerosis
due to the increase in the fraction of cholesterol transported by low-density lipoproteins (LDLc) and
reduction of the cholesterol transported by high-density lipoproteins (HDLc). Although there are
metabolism-derived trans-FAs in ruminant meat and dairy products, the negative aspects noted earlier
have been particularly associated with industrial trans-FAs sources obtained by partial hydrogenation
of vegetable oils. The White Paper on nutrition in Spain considers that the highest tolerable intake
(upper limit UL) for trans-FAs must be less than 1% of the total energy consumed [7]. In the same vein,
the Spanish Federation of Nutrition, Food, and Dietetics Societies (FESNAD) indicates that the intake
of trans-FAs must be as low as possible and not exceed 1% of the total energy [8]. The scientific report
of the European food safety authority (EFSA) on trans-FAs recommends the lowest possible content in
food [9]. The World Health Organization (WHO) recommends that total intake of trans-FAs should
not exceed 1% of the total energy of the diet, which is equivalent to less than 2.2 g/day for a 2000 kcal
diet. Currently, the “REPLACE program” is being introduced to eliminate trans-FAs in foods on a
global basis [10]. Margarines, which emerged as a substitute for animal fats, especially butter and are
produced through partial hydrogenation of vegetable oils, contain trans-FAs. So, for the industry, once
hydrogenation fats could no longer be used to harden fats, the alternative was palm fat, creating a
circular dynamic between increased demand, greater production, increased supply, lower prices, and
volatility in retail prices. What a priori seemed a reasonable replacement of one fat solution by another
is now a subject of wide-ranging debate, even transcending scientific and technical boundaries and
reaching consumers through social networks.
The consumption of palm oil is often questioned for various reasons: on the one hand, its effect on
cardiovascular health because of its composition; on the other, food security due to the possible accrual
of pollutants during refining; and finally, there is the debate on the sustainability of its cultivation
in the countries of origin. The food and nutrition sectors are increasingly adopting a more holistic
view, which encompasses not only health, but also environmental protection and traceability. The EU
promotes these with campaigns such as “From Farm to Fork” (tracing food from production to the
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table) [11], and the plan of action for the circular economy “Closing the loop” [12]. The circular
economy is an economic concept that interconnects with sustainability; its purpose is to ensure that
the value of products, materials and resources is maintained in the market for as long as possible,
as well as minimizing the generation of waste for disposal. As indicated by Marangoni et al., the
absence of any pronouncement from the scientific community regarding the effects of palm oil on
consumer health has meant that the message reaches the general public mainly through the mass
media and is often skewed and incomplete [3]. In light of the concerns observed among the Spanish
and European consumers, it seemed timely to conduct a multidisciplinary forum with ten scientific
experts in areas related to the topic (food, human and animal nutrition, dietetics, physical activity,
toxicology, sustainability, and public health) with a view to analyzing the existing knowledge, defining
research needs and agreeing on what data the message should convey to the consumer. The meeting
took place in Madrid on 3 July 2018. Every expert made an oral presentation reviewing the literature,
including legal aspects if needed, related to the topic based on his/her expertise, followed by a group
discussion. Presentations, scientific documents and discussions were used for the writing of this
document. The event was organized by the Improvement of Health by Fitness, Nutrition, and Exercise
(ImFINE) Research Group in collaboration with the Universidad Politécnica de Madrid and the Spanish
Foundation for Sustainable Palm Oil.
2. Sustainability of Oil Palm Crops
The concept of sustainability has evolved over the years. Initially, the Brundtland report [13]
defined the concept of sustainability as “meeting the needs of the present without compromising the
needs of future generations.” The Food and Agriculture Organization (FAO) extended the concept
of sustainability to the realm of food by defining sustainable diets as “those that generate reduced
environmental impact and contribute to the food security and nutrition and to current and future
generations to lead a healthy life. In addition, they protect and respect the biodiversity and ecosystems,
are culturally acceptable, accessible, economically fair and affordable and nutritionally adequate, safe
and healthy, and optimizing natural and human resources” [14]. Later, in 2014, the 8th report of the
FAO High Level Panel of Experts (HLPE) defined a sustainable food system as a food system that
ensures food security and nutrition for everyone in such a way as not to put at risk the economic, social,
and environmental foundations that help provide food security and nutrition to future generations [15].
In addition, the FAO proposes the following principles of sustainability for food systems:
• Management and conservation of natural resources.
• Efficient use of natural resources for production.
• Protection of rural livelihoods.
• Improvement of equity and rural welfare.
• Building the resilience of individuals and communities.
• Establishment of accountable and effective governance mechanisms, strengthening institutions
and investment.
In the same line, the United Nations Organization (UN) has established 17 sustainable development
goals (SDGs) for the period 2015–2030, summarized in Table 1 [16]. Goal number twelve refers in
particular to sustainable production and consumption, and goals two, three and six also have derivatives
which affect food production and the relationship between food and health. We must not forget that
the world population is expected to reach 8600 million by the year 2030, and 9800 million by 2050,
which certainly poses a problem of sustainability in itself [17]. The debate over palm oil is an example
of the complexity of producing food for a world population that has quadrupled in the last 100 years
(1920–2019) and continues to grow, especially in developing countries (Figure 1).
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Table 1. Sustainable development goals (SDGs) (UN 2015–2030) [16].
Goal 1 Goal 7 Goal 13
No poverty Affordable and clean energy Climate action
Goal 2 Goal 8 Goal 14
Zero hunger Decent work and economic growth Life below water
Goal 3 Goal 9 Goal 15
Good health and well-being Industry, innovation, and infrastructure Life on land
Goal 4 Goal 10 Goal 16
Quality education Reducing inequality Peace, justice, and stronginstitutions
Goal 5 Goal 11 Goal 17
Gender equality Sustainable cities and communities Partnerships for the goals
Goal 6 Goal 12
Clean water and sanitation Responsible consumption andproduction
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The sustainability of oil palm cultivation was first addressed in 2004 with the creation of the
Roundtable for Sustainable Palm Oil (RSPO). The principles of sustainable palm oil include the
protection of human rights in lands where it is produced. In addition, sustainable cultivation raises the
issue of protection of forests and animal life in these areas, requiring the farming practices that are best
suited to enhance performance and reduce crop expansion into new areas. The concept of sustainability
is therefore of special importance to finding a balance between future oil palm plantations and primary
forests. Palm plantations as part of sustainability programs may be the best possible alternative in
the new reality of these regions, promoting economic growth, respect for human rights and workers,
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improvement of communities involved in the production of sustainable palm oil, and the conservation
of natural resources, as well as avoiding overexploitation to ensure responsible production now and in
the future [18]. The lines of action of the RSPO are defined in 7 principles, summarized in Table 2.
Table 2. Roundtable for Sustainable Palm Oil (RSPO) principles [18].
1. Behave ethically and transparently
2. Operate legally and respect rights
3. Optimize productivity, efficiency, positive impacts and resilience
4. Respect community and human rights and deliver benefits
5. Support smallholder inclusion
6. Respect workers’ rights and conditions
7. Protect, conserve and enhance ecosystems and the environment
In addition to the certification of sustainability, the RSPO provides for several models in the
industry supply chain today: Preserved identity (PI), segregated (SG), and mass balance (MB). The PI
model assures that RSPO-certified palm oil products offered to the end consumer come from a single
plantation and its bases of supply, and they are physically isolated from other sources of palm oil
throughout the supply chain. The SG model means that RSPO-certified palm oil products offered to
the end consumer come only from RSPO-certified sources. Certified palm oils from different sources
may be mixed. In the MB model, the marketing of RSPO-certified palm oil products is controlled
throughout the supply chain to ensure the regulation of trade in sustainable palm oil. This model
allows the mixing of RSPO-certified with non-certified oils at any point in the supply chain [19].
Palm oil cultivation is only possible in tropical areas where the density of primary forest is the
highest in the world. Such cultivation has been brought into question because it promotes deforestation
and destruction of the habitat of orangutans in Borneo. Voigt et al., say that the population of
orangutans in Borneo fell by 148,500 between 1999 and 2015 because of poaching, logging, deforestation
and monoculture plantations, showing that demand for natural resources itself has eliminated more
than 100,000 orangutans [20]. In this connection, European Parliament resolution 2016/2222 on palm
oil and deforestation of rainforests is one of the most important documents so far on the effects of the
production and consumption of palm oil in the world. This document reflects the pros and cons of
palm oil, but also opens the door to the use of sustainable palm oil to fight against aspects that do
not comply with the principles of sustainability. The document highlights that almost half of current
tropical deforestation (49%) is the result of illegal logging caused by commercial agriculture and that
this destruction is driven by external demand for agricultural commodities such as palm oil, beef, soya,
and timber products. Moreover, it estimates that the illegal conversion of rainforests for the purpose
of commercial agriculture produces 1.47 gigatons of carbon every year, equivalent to 25% of annual
emissions from fossil fuels in the EU. It should be recalled that the cultivation of palm spans several
continents (Figure 2) [21].
An analysis by Bayona Rodríguez et al., noted that oil palm was one of the plants most widely
exploited by agribusiness. As well as having a great potential for carbon capture, it requires little
water for cultivation, characteristics that favor its sustainability. Assessments conducted in an African
palm (E. guineensis) plantation in the Colombian municipality of Barrancabermeja found that the daily
posting of carbon per hectare (Ha) was 29 kg [22]. The rate of CO2 fixation per kg of oil yield is quite
high, and although calculated by Ha is less than that of sugar cane, with about 44 kg/Ha/day, it is
well above other major crops such as corn or sugar beet. Research has highlighted the vast carbon
capture potential of this type of crops, which could reduce greenhouse gas emissions and possibly help
alleviate climate change. In addition, transpiration rates are not high (1.2–1.5 mm/day as against 4–4.5
mm/day for other rainforest crops) and the water requirement is low, which gainsays the notion that
this plant dries the ground. In fact, in the ecosystem of palm oil cultivation (palm, soil, weed plant) 70%
of the used water resources is determined by the soil transpiration and undergrowth that accompanies
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these crops (weed plant), and only 30% by Palm. In this connection, other authors propose measures
to improve the cultivation of oil palm and make it even more sustainable [23].
Nutrients 2018, 10, x FOR PEER REVIEW  5 of 36 
 
Table 2. Roundtable for Sustainable Palm Oil (RSPO) principles [18]. 
1. Behave ethically and transparently 
2. Operate legally and respect rights 
3. Optimize productivity, efficiency, positive impacts and resilience 
4. Respect community and human rights and deliver benefits 
5. Support smallholder inclusion 
6. Respect workers’ rights and conditions 
7. Protect, conserve and enhance ecosystems and the environment 
In addition to the certification of sustainability, the RSPO provides for several models in the 
industry supply chain today: Preserved identity (PI), segregated (SG), and mass balance (MB). The 
PI model assures that RSPO-certified palm oil products offered to the end consumer come from a 
single plantation and its bases of supply, and they are physically isolated from other sources of palm 
oil throughout the supply chain. The SG model means that RSPO-certified palm oil products offered 
to the end consumer come only from RSPO-certified sources. Certified palm oils from different 
sources may be mixed. In the MB model, the marketing of RSPO-certified palm oil products is 
controlled throughout the supply chain to ensure the regulation of trade in sustainable palm oil. This 
model allows the mixing of RSPO-certified with non-certified oils at any point in the supply chain 
[19]. 
Palm oil cultivation is only possible in tropical areas where the density of primary forest is the 
highest in the world. Such cultivation has been brought into question because it promotes 
deforestation and destruction of the habitat of orangutans in Borneo. Voigt et al., say that the 
population of orangutans in Borneo fell by 148,500 between 1999 and 2015 because of poaching, 
logging, deforestation and monoculture plantations, showing that demand for natural resources itself 
has eliminated more than 100,000 orangutans [20]. In this connection, European Parliament 
resolution 2016/2222 on palm oil and deforestation of rainforests is one of the most important 
documents so far on the effects of the production and consumption of palm oil in the world. This 
document reflects the pros and cons of palm oil, but also opens the door to the use of sustainable 
palm oil to fight against aspects that do not comply with the principles of sustainability. The 
document highlights that almost half of current tropical deforestation (49%) is the result of illegal 
logging caused by commercial agriculture and that this destruction is driven by external demand for 
agricultural commodities such as palm oil, beef, soya, and timber products. Moreover, it estimates 
that the illegal conversion of rainforests for the purpose of commercial agriculture produces 1.47 
gigatons of carbon every year, equivalent to 25% of annual emissions from fossil fuels in th  EU. It 
should be recalled th  the cultivation of palm spans several con inents (Figure 2) [21]. 
 
Figure 2. Map of palm oil producing countries (United States Department of Agriculture (USDA), 2018). 
Figure 2. Map of palm oil producing countries (United States Department of Agriculture (USDA), 2018).
In 2013, the European Palm Oil Alliance (EPOA) was founded, a business initiative to involve and
educate those interested in the full story of palm oil. This is an international project working closely
with active national initiatives in different European countries, providing science-based communication
and creating a balanced view about nutritional aspects and sustainability of palm oil. EPOA strongly
supports the adoption of 100% sustainable palm oil.
On 7 December 2015, industry, civil society and Governments signed the “Amsterdam Declaration”.
This calls for the inclusion of sustainability throughout the food production chain covered by the RSPO,
which has established a commitment for implementation of 100% sustainable palm oil in the European
chain for 2020. Signatory countries of the Amsterdam Declaration include the United Kingdom,
Germany, Italy, Denmark, Norway, and the Netherlands [24].
Spain is one of the largest importers of palm oil in the EU, although an important part is re-exported,
and together with Italy it is one of the countries whose food industry imports least sustainable oil
according to a report prepared by the European Sustainable Palm Oil Organization “Making sustainable
palm oil the norm in Europe” [25]. This report shows that 69% of the palm oil used in Europe was
sustainable in 2016. Spain, Italy, Germany, and Holland are the European countries that import most
palm oil, and moreover are major distributors in the European market. This report also reveals that
60% of imported palm oil for food in Europe is officially RSPO certified (Certified Sustainable Palm
Oil, CSPO). According to the “Economic Report on palm oil in Spain 2018”, in 2016, 23.7% of palm oil
marketed in Spain was CSPO. This percentage rose to 29.9% in 2017, and reached 43.7% in 2018 [26].
As for palm kernel oil, in 2016 the CSPO rate was 14.9%, a percentage that remained stable in
2017, approaching 18% in 2018 [26]. This does not mean that all other palm oil or palm kernel oil is
not sustainable; it only means that it is not certified as such. Nowadays, all the palm oil imported in
Spain is traceable to the factory where it has been produced in the country of origin, and although
it does not come with the RSPO certification, in many cases the marketing companies have their
own ‘non-deforestation’, ‘No sowing in wetlands (peat-lands)’, ‘No labor exploitation’ and other such
policies. In this connection there are other entities and non-governmental organizations (NGOS) such
as The Forest Trust (TFT) that control the traceability of the raw material.
As regards sustainability, it is worth noting that 100% of the palm oil used for biofuels is certified
by the ISCC (International Sustainability and Carbon Certification) scheme, approved by the EU
through Directive 2009/28/EC on promotion of the use of energy from renewable sources [27].
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Following the ESPO document, during 2016 the EU acquired a total of 7.07 Mt of palm oil,
equivalent to 11% of world production, making it one of the three largest importers along with China
and India. Of the total imported to the EU in 2016, 3.7 Mt went to the food industry, while the remaining
3.4 Mt went to the energy sector [25].
Today, food production systems and excess food wastage, present more than reasonable doubts
as to whether the current system of food production and distribution is sustainable. According to
the FAO report “Food Wastage Footprint. Impacts on Natural Resources”, 1.3 billion tons of food are
wasted annually, causing great economic loss and serious damage to the natural resources on which
humanity depends to feed itself. It is estimated that after the US and China, the greatest source of
greenhouse gases (GHG) is the huge amount of food waste generated in the world (more than 1/3 of
the total) [28]. According to Ignacio Trueba, FAO representative in Spain at the 6th AECOC meeting
against food waste in Madrid in September 2018, if food waste was a country, it would be the third in
the world in GHG production [29], a total of approximately 3.3 billion tons of CO2 per year [28]. This
is also an important factor to take into account when it comes to talking about sustainability, like the
water footprint, the carbon footprint, and the ecological footprint of food production.
Thanks to the work done over the last few years, palm oil is one of the leading products in
sustainable production; however, there is also evident concern about sustainability in various crops
globally. For example, in the case of rice, the Sustainable Rice Platform (SRP), the International Rice
Research Institute (IRRI) and the UN are working on a certification that, like Fair Trade stamps or the
RSPO, credit the rice planted under certain sustainable criteria. The IRRI published the standards in
2015 and is now revising the 46 base criteria, which range from use of water and fertilizers to social
and labor criteria. The project also seeks to establish a compliance verification system, through audits,
as a means to check on the ground that the minimum principles are fulfilled [30].
In the case of soy, the Roundtable for Responsible Soybean Production (RTRS, Round Table
Responsible Soy) was created in 2009. It has a 5-year certification system based on the RTRS standard
for responsible soy production and contemplates aspects similar to certificates for other crops: good
farming practices, good working conditions for small producers, etc. [31]. In 2018 world soybean
production was 350 Mt, of which 4,470,000 (1.28%) was RTRS certified product [32,33].
The UTZ sustainability certificate ensures that the raw material with which products are made
is produced following sustainability criteria. This organism certifies, supervises and promotes
improvements in farms to protect the environment, the workers and the communities where the raw
materials are exploited. It currently certifies cocoa, coffee, tea, and hazelnut plantations [34].
3. Importance of Fats in Foods
Palm oil is included within the group of edible fats. Be it remembered that fats help to improve
palatability, favor the release of flavors and aromas of meals and contribute to the feeling of satiety [35].
Sometimes maligned, partly because of its caloric content (9 kcal/g), fat is a nutrient that fulfils
important functions in the organism, such as in embryonic development, or transport, metabolism
and maintenance of the membrane function and integrity, cellular growth, and maintenance of tissues,
brain development and vision, and transport of fat-soluble vitamins (A, D, E, K) [7,36–38]. Of all the
FAs that make up fats, two are essential nutrients: linoleic acid of the omega-6 family (C18:2,ω-6) and
alpha-linolenic acid of the omega-3 family (C18:3,ω-3). Both are precursors of other longer-chain more
unsaturated FAs such as Dihomo-gamma-linolenic acid (C20:3,ω-6), Arachidonic acid (C20:4, ω-6),
Eicosapentaenoic acid (C20:5,ω-3) and Docosahexaenoic acid (C:22,ω-3), precursors in turn of active
biomolecules such as eicosanoids (20 carbon atoms) and docosanoids (22 carbon atoms). Eicosanoids
include prostaglandins, prostacyclins, thromboxanes, leukotrienes, hydroperoxyeicosatetraenoic acid
(HETE), lipoxins, or resolvins of the E series. Prominent among the docosanoids are neuroprotectins,
maresins, and resolvins of the D series.
It is worth noting that depending on the FA from which they come, eicosanoids display different
(even opposite) properties in terms of platelet aggregation, vasoconstriction, inflammation, and
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chemotaxis, among others [7,38], so that an appropriate ratio between FAω-6 andω-3 is essential to
avoid quasi-exclusive consumption of FAs of one or other family.
Cholesterol is one of the lipids of animal origin and is a fundamental element for our organism,
since it is present in the cell membranes and is a precursor of hormones (progesterone, testosterone,
cortisol, aldosterone, etc.), acids and vitamin D. In general, it can be said that vegetable fat sources
such as palm oil do not contain cholesterol and contain more linoleic than alpha-linolenic acid.
Body fat is the most efficient way of storing fat (less space and demand for water, and higher
energy efficiency) to maintain an energy reserve. Fat surrounds the organs and bones of our body,
protecting from blows and traumas, and plays an important role in the face of cold and hypoglycemia.
It should not be forgotten that the composition of cooking fat very much conditions the quality of the
fat in the diet we consume [7]. The recommendations for daily intake of fats are 20%–35% of the daily
energy supply, which for a standard diet of 2000 Kcal is around 45–75 g/day. Rather than total fat,
for which the margin of recommended intake is an ample one, scientific associations emphasize the
contribution of the different FAs (saturated (SFA), monounsaturated (MUFA), and polyunsaturated
(PUFA) of theω-6 andω-3) families [37,38].
However, these recommendations have the disadvantage of generalizing, glossing over particular
aspects of great importance. Thus, not all SFAs or PUFAs have the same effect on cholesterol, platelet
aggregation, or thrombogenesis. The position of the FA in the triglyceride molecule (TG) conditions its
effect, so at present there are no consensus recommendations for individualized consumption of the
different FAs [39]. The American Heart Association (AHA) and the FAO/WHO emphasize reduction
of SFA intake (10% of total energy) [37,40], while the FESNAD stresses assurance of a high intake of
MUFAs (>20% of total energy) and essential FAs, the percentage difference being made up of SFAs
and all the other PUFAs [41]. This means that fat intake has to be analyzed in the context of the diet,
depending on whether it is Western type (AHA, FAO/WHO) or the Mediterranean type (FESNAD)
(Table 3).
Table 3. Different criteria for fat intake recommendations for healthy adult population.
WHO/FAO (2010)
[37] FESNAD (2015) [41] AHA (2000) [40]
Total fat 20%–35% 20%–40% 30%
SFA <10% The recommendations are reducingthe SFA-rich foods intake. <10%
MUFA Calculated bydifference
12%–30% (27–67 g/day) 20%–25%
(45–55 g/day) * Calculated by difference
PUFA 6%–11% <10%
PUFA W3
Alfa linolenic acid
DHA + EPA
0.1%–1% (0.25–2.25 g/day) 0.5–1%
PUFA W6 0.5%–2% 5%–10% (10–20 g/day)
Trans-FAs <1% 2%–3% Reduce the intakeas much as possible
Cholesterol <300 mg/day
* PREDIMED study data. Modified from Gesteiro et al., (2018) [39]. Fatty acids (FAs): saturated (SFA),
monounsaturated (MUFA); and polyunsaturated (PUFA).
3.1. Fat Intake in Spain
The data from the ANIBES study carried out on a representative sample of the Spanish population
situate the average daily energy intake at 1810 ± 504 kcal (between 1957 ± 531 kcal for men and
1660 ± 427 kcal for women) [42]. Total fat contributes 38% of Kcal, of which MUFAs contribute 16.8%,
SFAs 11.7%, PUFAs 6.6%, ω-6 FAs 5.4%, and ω-3 FAs 0.6% [42]. Fat sources in the Spanish population
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are mostly derived from the consumption of oils, principally olive (32%), followed by meat (22.5%),
and dairy products (13.5%). In the case of SFAs, the food groups are the same, although in different
order: meat (25.7%), dairy products (23.7%), and oils (21.4%) [42]. A food consumption report in
Spain 2018 shows that olive oil consumption was 3.8 liters/person/year (L/p/y), milk 69.8 L/p/y, dairy
derivatives 35.5 L/p/y, fresh meat 33.5 kg/p/y and processed meat 11.6 kg/p/y. Consumption of the
pastries and biscuits group was 5.9 and 5.2 kg/p/y, respectively [43].
Recent publications have shown there is a lack of data regarding palm oil intake in Europe and
Spain [3,39]. It is necessary to contextualize the content of palm oil in foodstuffs and a Mediterranean-
type diet. The palm oil present in our diet comes from products located at the top of the food pyramid,
so-called indulgence foods, which should only be consumed occasionally. The current problem is that
despite the decrease in calorie consumption, the diet is saturated by an increase in the frequency of
consumption of indulgence products. The excess energy induced by a positive energy balance presents
a new scenario in the interpretation of health and nutrition. Physical activity exerts a regulatory effect
on the energy balance greater than the caloric intake [44]. Physical inactivity promotes a constant
positive energy balance, and in the Spanish population, sedentary rates exceed 70% and more than
one third of the population fails to comply with the minimum recommendations of daily physical
activity [45,46].
3.2. Complexity of Fat Metabolism
When assessing what fraction of the food we ingest is absorbed in the organism and subsequently
metabolized, it is essential to consider the concepts of bioaccessibility and bioavailability. Bioaccessibility
means the maximum fraction of the nutrient that can be released from the food matrix in the
gastrointestinal tract, while bioavailability is the fraction that reaches systemic circulation from the
gastrointestinal tract and which is available to promote its action within the organism.
The majority of the fats in foodstuffs are composed of TGs, which need to be hydrolyzed into
FAs and glycerol before being absorbed. The disposition of the FAs that are attached to the skeleton
of the glycerol in the TG molecule generates a stereospecific molecule that determines its absorption.
Pancreatic lipase hydrolyses positions sn-1 and sn-3 FA, generating 2-monoacylglycerides (2-MAG)
and free FAs (FFAs). In the presence of divalent ions (e.g., calcium), the SFAs released from positions
sn-1 and sn-3 form insoluble soaps that are not absorbed. This singularity is lost when the SFAs are
in the sn-2 position of the TG. FFAs and MAGs are absorbed directly by diffusion in the enterocytes
of the intestinal wall. The phospholipids are hydrolyzed by the phospholipase A2, producing FFAs
and lysophospholipids. FAs with chain lengths greater than 14 carbon atoms are re-esterified in the
enterocyte and are circulated through the lymphatic pathway in the form of chylomicrons. Short and
medium chain FAs go directly to the liver through the portal vein. Cholesterol esters are hydrolyzed by
pancreatic hydrolase of cholesterol esters. Fat-soluble vitamins and cholesterol also reach the systemic
circulation incorporated in the chylomicrons.
This complicates the study of fats in general, and palm oil in particular, in that such studies need
to take into account not only FA composition but also positioning within the TG.
4. Nutritional Composition of Palm Oil
The FA balance of palm oil is around 48% SFA and 52% unsaturated (UFA)—that is, in terms of
SFA values, higher than other oils such as sunflower, olive, or rapeseed which are classified as healthy,
and well below coconut oil, which has a high SFA content, mainly myristic and lauric. Palmitic acid
is the most abundant of palm oil SFAs, reaching 85%. And for its part oleic acid is the largest UFA
component (88%) in palm oil. In addition, the content of FAs such as lauric acid (12 atoms of C) and
myristic acid (14 atoms of C) accounts for 1.5% of SFAs, which is very minor compared to coconut oil.
In palm oil, 80% of the oleic acid is located at the sn-2 position of the TG, so it is quickly absorbed
as MAG. Based on the stereospecificity of the positioning of the FA in the TG and the bioavailability of
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the FA in sn-2, mainly oleic acid, palm oil may be considered to act as a MUFA on the plasma lipid
profile [47,48].
Palm oil is more complex than simply the oil per se, as the composition of the different fractions
currently marketed and used by the industry depart from the standard 50%/50% profile. In this context,
palm olein contains 44% SFA and 56% UFA. Its characteristics make it more liquid, and it is normally
used in the industry for potato crisps, etc. At the other end of the spectrum is the palm stearin fraction,
with a higher SFA content (68%) and a lower UFA content (32%), which is used to make products
such as croissants that require more solidity, and is an alternative to the use of hydrogenated oils,
so reducing the intake of trans-FAs (Table 4).
Table 4. Fatty acid composition (%) of the different palm oil and kernel oil fractions.
Fatty
Acid Palm Oil
Palm
Stearin
Palm
Olein
Palm
Superolein
Palm
Kernel Oil
Palm Kernel
Stearin
Palm Kernel
Olein
C6:0 ND ND ND ND ND-0.8 ND-0.2 ND-0.7
C8:0 ND ND ND ND 2.4–6.2 1.3–3.0 2.9–6.3
C10:0 ND ND ND ND 2.6–5.0 2.4–3.3 2.7–4.5
C12:0 ND-0.5 0.1–0.5 0.1–0.5 0.1–0.5 45.0–55.0 52.0–59.7 39.7–47.0
C14:0 0.5–2.0 1.0–2.0 0.5–1.5 0.5–1.5 14.0–18.0 20.0–25.0 11.5–15.5
C16:0 39.3–47.5 48.0–74.0 38.0–43.5 30.0–39.0 6.5–10.0 6.7–10.0 6.2–10.6
C16:1 ND-0.6 ND-0.2 ND-0.6 ND-0.5 ND-0.2 ND ND-0.1
C17:0 ND-0.2 ND-0.2 ND-0.2 ND-0.1 ND ND ND
C17:1 ND ND-0.1 ND-0.1 ND ND ND ND
C18:0 3.5–6.0 3.9–6.0 3.5–5.0 2.8–4.5 1.0–3.0 1.0–3.0 1.7–3.0
C18:1 36.0–44.0 15.5–36.0 39.8–46.0 43.0–49.5 12.0–19.0 4.1–8.0 14.4–24.6
C18:2 9.0–12.0 3.0–10.0 10.0–13.5 10.5–15.0 1.0–3.5 0.5–1.5 2.4–4.3
C18:3 ND-0.5 ND-0.5 ND-0.6 0.2–1.0 ND-0.2 ND-0.1 ND-0.3
C20:0 ND-1.0 ND-1.0 ND-0.6 ND-0.4 ND-0.2 ND-0.5 ND-0.5
C20:1 ND-0.4 ND-0.4 ND-0.4 ND-0.2 ND-0.2 ND-0.1 ND-0.2
C20:2 ND ND ND ND ND ND ND
C22:0 ND-0.2 ND-0.2 ND-0.2 ND-0.2 ND-0.2 ND ND
C22:1 ND ND ND ND ND ND ND
C22:2 ND ND ND ND ND ND ND
C24: 0 ND ND ND ND ND ND ND
C24:1 ND ND ND ND ND ND ND
Source: Codex Alimentarius (2015) [49].
The percentage of SFAs is generally higher in animal fats (meat, dairy), so the replacement of
animal by vegetable fats appears a favorable alternative. The debate currently focuses on the FA
composition of vegetable oils, especially palm oil. When comparing palm oil with fats of animal
origin that have a FA profile similar to lard and are less saturated than butter, be it noted that since an
important part of the palm oil SFAs are in position sn-1 and sn-3, SFA absorption is lower and hence its
potentially negative effects for cardiovascular health are also lower (Figure 3). It is worth noting that in
addition to these stereospecific differences, palm oil differs from butter in that it contains less butyric
(not detectable vs. 3.32%) and stearic acids (3.5%–6% vs. 9%), and more oleic (36%–44% vs. 22%) and
linoleic (9%–12% vs. 1.1%) acids [49–51].
Palm is one of the most stable oils, prolonging food storability. The resistance of products with
palm oil to rancidity derives not only from its SFA content, but also from its antioxidant components
(mainly tocotrienols and tocopherols), thus avoiding lipid peroxidation and the consequent formation
of free radicals. However, during the refining process, the antioxidant content of palm oil is reduced
dramatically. In Spain only refined palm oil is permitted [4].
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Palmitic Acid
One of the arguments underpinning the questioning of palm oil healthfulness is its SFA content,
and specifically the relationship of palmitic acid to cardiovascular health [52,53]. Palm oil is often
mistakenly identified with palmitic acid, and we therefore consider it necessary to look more closely
at the nutritional and metabolic aspects of this FA. The first thing to emphasize is that palmitic acid
is a long chain SFA (16 carbons), and not only is not itself a toxic compound, but is synthesized
endogenously in the organism; in fact, it is the most abundant FA in the human body, accounting for
between 20%–30% of total FAs. It is an essential component of cell membranes, secretory lipids, and
transport and is part of the ormal composition of the human organism [54]. It is found especially
in fetus fats (45%–50% of FAs) and in breast milk [54,55]. It has other functions in ddition t he
production of energy, suc as the ability to join certain proteins necessary for some functions of the
nervous system, to promote the formati n of the pulmonary surfactant or to guarantee the binding
between cells [56].
The richest foods in pal itic acid are dairy products, meats (fa ty cuts of red me t and poultry
skin, such as chicken) and vegetable oils (particularly palm and coconut). Human milk is richer in
palmitic acid than cow’s milk. In fact, it is the most abundant FA n the composition of that milk,
accounting for between 20% and 25% of the FAs. Like most animal fats, palmi c acid is ma nly loca ed
in the sn-2 position of the TG, in such a way that promotes it absorption. Pal oil is used as an
ingredient in follow-on ilks and infant milks, and should be inte esterified, since in palm oil, palm tic
acid does not preferentially occupy the sn-2 position.
A r cent review of opinion delves into the effect of diet and the synthesis of ndogenous palmitic
ac d through de novo metabolic pathway lipogenesis, focusing atte tion on the i portan e of a
b anced UFA/SFA ratio in the phospholipid membrane, and especially mphasiz ng the role of the
PUFAs i this alanc [56]. From a metabolic point of view, an imbalance in the SFA/UFA ratio can
promote de novo lip gen sis and cholesterol syn hesis and moreove , he replacement of SFA by
PUFAs can i duce an i crease in the p lmitic acid levels in the tissu through de novo lipogenes s.
The endogenous syn hesis of palmiti acid is also reviewed, explaining the mechanisms that can
potentially int nsify this process, such as an exc ss of energy in the diet. And again, it relates de
novo lip genesis to the emergen e of cancer, in that this is a preferential metabolic pathway in most
tumors and explains th s process at the molecular level. It stresses the intake of nutrien s through
SFA/PUFA balance; it explains the CD36 FA recep r and the role of palmitic acid in its activatio ,
menti ning the study by Pascual et al., [57], but it also raises the need to study the behavi r of CD36
as a receptor in the i take of other sources of energy, such as other FAs r carbohydrate-rich diet .
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The conclusion is that under normal physiological conditions, it is de novo lipogenesis which regulates
the accumulation of palmitic acid in tissues; however, in situations such as positive energy balance or
inactivity/sedentarism, mechanisms responsible for maintaining equilibrium in the concentrations of
palmitic acid in the tissues are interrupted, causing dyslipidemia, hyperglycemia, fat accumulation
and inflammation.
Authors should discuss the results and how they can be interpreted in perspective of previous
studies and of the working hypotheses. The findings and their implications should be discussed in the
broadest context possible. Future research directions may also be highlighted.
5. Palm Oil and Its Effects on the Lipid Profile
The relation of palm oil with CVD has been widely studied [7,58,59], and there are numerous
systematic reviews and meta-analyses in this respect [52,60–62].
The results reported by Temme et al., suggest that medium chain FAs (between 6 and 12 carbons)
raise the TG level, but have little effect on TC and HDLc levels [58]. In addition, they do not induce
lipogenesis and are quickly used up for energy purposes by means of beta-oxidation, unlike long chain
FAs, particularly all the SFAs that are stored through high intake, promoting obesity [7].
Some authors have related palm oil intake to cardiovascular health problems [59], but recent
reviews indicate that there is no real scientific evidence for it [61,63]. It is worth noting that in the
countries where this oil is used for frying, the number of deaths attributable to this pathology is no
higher than in importing countries (Malaysia 35%, Indonesia 35%, Germany 37%, Spain and Belgium
28%, and USA 30%) [64]. This suggests that it is not so much the oil that is used, as the diet as a
whole, as well as lifestyle. In fact, high SFA intake in the context of a hypercaloric diet induces insulin
resistance and less satiety than in conditions of limited intake and low fat intake, when the effects are
lesser [65].
The reviews by Fattore et al., and Sun et al., show an increase of LDLc and TC with age and
consumption of diets rich in palm oil [52,60]. Recently, Gesteiro et al., analyzed these studies in depth,
observing discrepancies when defining the FA profile of the oils used in the plasma lipid profiles of
the populations studied, as well as the oil considered as an ingredient or dressing. Physical activity,
often forgotten in nutrition studies, is another of the variables that have not been considered in most
studies [39].
Recent reviews of studies on the effect of palm oil intake on plasma lipid profile have observed that
many of these studies have not been taken into account when analyzing results for the position of the
FA in the TG [48,66–68]. Another little-studied but no less important aspect is the effect that the most
saturated oils used in the studies exert on lipoprotein oxidation. Some authors suggest that this type of
research should include the lipoprotein used in biomarkers of CVR in foals, such as apolipoproteins
(APO) APO A1 and APO B (some linked to specific polymorphisms). In this respect, few studies have
gone further into the effects of palm oil consumption or its fractions. Some authors posit a raising
of Apo A1 levels [52]. Cuesta et al., studied the effects of consumption of a palm olein on high oleic
sunflower oil in a controlled population of postmenopausal women. This intervention consisted
in replacing 9% of the energy in the diet derived from oleic acid with palmitic acid (approximately
18 g of total SFA or 18 g palmitic acid). There were considerable increases of both LDLc (21.6%) and
HDLc (14,9%), but LDLs were less oxidized (70% less peroxides); this was a consequence, among
other aspects, of very significant (p < 0,001) beta-carotene, (All-E)-beta-carotene and cryptoxanthin
demand, although there was a decrease of lycopene [69]. This is an important aspect in that oxidized
LDLs and not LDLc are decisive in initiating the atherogenic process [70,71]. They also observed a
non-significant reduction (3%) in APO A1 levels, with a higher APO B level (11.8%) and a reduced
APO A1/APO B ratio (22.8%), suggesting an increase in CVD risk after consumption of some palm oil
fractions. However, no significant changes were found in other very predictive markers of CVR such
as the quotient of total cholesterol (TC)/HDLc or LDLc/HDLc. Subsequently, Sánchez-Muniz et al.,
observed that the same dietary change induces a very significant increase in the HDL APO A2/APO
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A1 ratio [72]. Since the increase in APO A2 levels is considered a limiting factor in the esterification
of cholesterol via lecithin cholesterol acyl transferase (LCAT), retrograde cholesterol transport and
antiatherogenic capacity of HDL [73], this change is considered non-beneficial. The exchange of the
two oils also induced rises in thromboxane A2 levels (TXA2, measured as thromboxane B2), with
platelet activity, and to a lesser extent also prostacyclin I2 (PGI2). The net change involved increases in
the antiphospholipid TXA2/PGI2 index, suggesting a prothrombogenic effect post-intervention [74].
Manipulating the fat in the diet can have beneficial effects in terms of both quantity and
composition, although the response is not homogeneous throughout the population, in which
individuals have been defined as normo-, hyper-, and hyporesponders. In fact, in studies where high
oleic sunflower oil was replaced with palm olein in postmenopausal women, as noted above, the
most important differences in the oxidized LDL, APO A2 and APO A1/APO A2 ratios were found in
women with hypercholesterolemia, with no major differences in other markers between normo- and
hypercholesterolemia. This difference in response is linked to nutrigenetic mechanisms that relate to
the presence of risk alleles in certain candidate genes [75,76].
In a recent double-blind, cross-over randomized intervention study conducted in China, comparing
the daily intake of 48 g of olive oil with 48 g of palm oil in 120 adults for 2 months with a washout
period of 2 weeks, no differences in the effect on body fat and plasma lipid profile were observed [77].
Whereas trans-FAs act to reduce levels of HDLc, palm oil has been shown to increase HDLc
values. In addition, the increase in LDLc is significantly greater when trans-FAs are consumed rather
than palm oil. When a vegetable fat (palm oil) is compared to an animal fat (lard), there are also
improvements in the lipid profile, despite the FA composition being similar in some cases. These data
support the theory cited above as to the importance of FAs in the sn-2 position. Hence, with what we
know to date, it is fair to say that vegetable fats (in this case palm oil) constitute a healthier alternative
for lipid profiles than trans-FAs [52,60].
Schwingshackl et al., recently published an interesting meta-analysis whose main objective was
to analyze the effect of a series of 13 fats and oils on LDLc levels, including a secondary analysis of
the effects on TC, HDLc, and TG. To do this, they analyzed 54 studies published between 1984 and
2018, with a total population of 2065 participants. All of them were randomized trials, comparing
at least two of the 13 oils and fats contemplated. TC, LDLc, HDLc, and TG were analyzed for the
plasma lipid profile. Safflower, rapeseed, flaxseed, sunflower, corn, olive, soybean, palm, and coconut
oils, and beef fat, were the ones that most reduced LDLc and TC when used to replace 10% of the
dietary energy intake from butter. Safflower, sunflower, rapeseed and corn reduced TC much more
than coconut or palm, while safflower, sunflower and rapeseed were more effective than olive oil in
reducing TC. The replacement of 10% of the energy from butter with the equivalent in sunflower,
palm, olive or coconut oil, raised HDLc concentrations. Coconut and palm oil raised HDLc more than
corn or soybean. In the case of TG, the oils that most effectively reduced plasma concentrations were
sunflower, soybean, and palm. When comparing oils with beef fat, the ones that most reduced TG
plasma concentrations were safflower, sunflower, corn, soybean, and palm. Palm oil was found to
be more effective in improving HDLc than oils with lower SFA content; and when compared with
UFA-rich oils, it increased both plasma LDLc and HDLc concentrations. The quality of the evidence
was moderate for TC and poor or very poor for LDLc. In the case of HDLc and TG, the evidence turned
out to be moderate [62]. The explanation for this low evidential level may include the small number of
studies analyzed, risks of error, inaccuracies and inconsistency of some comparisons. It is striking
that the authors did not consider cocoa butter, which is rich in SFAs and is widely used. In the case of
palm oil, a standard FA composition was considered, which can cause errors, since the behavior of the
different palm oil fractions differs according to the cardiovascular profile. The time interval considered
is very long, and this should be taken into account, since the analytical techniques used to determine
the different cardiovascular profile markers have evolved a lot during the 34 years covered by the
review and this may not have been taken properly into account.
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The authors of a recent review, which includes four studies on coronary heart disease and palm
oil (all conducted in Costa Rica and belonging to the same research over time), and one that analyses
the association of accident stroke with palm oil, called attention to a few studies included in the review
after applying the PRISMA methodology (Presentation of Systematic reviews and Meta-Analysis).
Although they found an association between palmitic acid and the risk of myocardial infarction, there
was no such association with total SFA intake. The authors insist that many factors recognized in
relation to CVR, such as hypertension, diabetes, alcohol use, lack of physical activity, tobacco, etc., are
responsible for 90% of the population attributable risk. They also suggest that instead of considering
nutrients in isolation, the diet should be analyzed as a whole. It is evident that research of greater
scientific and technical quality is needed in relation to the consumption of palm oil and CVR. In the
conclusions, which according to the authors should be considered with caution, they indicated that
there is no evidence of an association between the consumption of palm oil and risk of death from CVD.
Likewise, they pointed out some needs identified in relation to research in palm oil, such as (1) to assess
the consumption of palm oil quantitatively and with greater rigor; (2) to analyze the consumption of
palm oil independently of other foods; (3) to conduct studies of sufficient depth and duration; (4) to
adjust to the known CVR factors when performing statistical analysis; and (5) to include countries
with high palm oil consumption in the studies. This review highlights the difficulty in establishing
differences between types of fats, FA sources, and the effects of replacing some fats with one another,
since they depend on the dietary context where the study is conducted and on the research design [61].
In preparing reviews or meta-analyses with nutritional studies, several difficulties arise when
making estimates of the composition, such as differences in the composition of food over the years, state
or companies’ own reformulation programs, or labelling regulations. Faced with this situation, the
question is how extensive are the studies that have been published so far, or if the results are extrapolated
to the present day taking these possible variations into account. In studies of cardiovascular disease
(CVD) of only a few years ago, the biomarkers that were used were HDLc/LDLc, in addition to TC
and TG. Moreover, different HDL fractions (HDL1, HDL2, HDL3) and the sizes and density of LDL
were studied to determine their degree of atherogenicity. In reviews and studies on palm oil, these
biomarkers are not presented. Unfortunately, and quite possibly due to financial constraints, both in
clinical trials and in many research projects, the parameters studied are almost exclusively TC, TG,
LDLc, and HDLc, ignoring the prognostic value of other protective markers and CVR.
Some reviews and published meta-analyses are summarized in Table 5.
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Table 5. Reviews on the effect of palm oil on cardiovascular health.
Reference Type of Study and Aims Results and Conclusions
Bester et al.
[78]
Review. To identify the benefits and risks of four edible oils (olive,
sunflower, fish and palm oils) for cardiovascular health.
The studies reviewed here suggest that all four oils could be suitable for inclusion
in a healthy diet. Beneficial effects have been identified for each one, although in
some cases there remains some dispute.
In the case of palm oil, the bulk of the studies have addressed its effects on the
serum lipid profile, concluding that the lipid profile is unaffected, and can even
reduce atherosclerosis and prevent cardiac ischaemia. The few studies addressing
the effect of palm oil on arrhythmogenesis are inconclusive, although it can
apparently have a slight anti-arrhythmogenetic effect.
The studies performed with extracts of the tocotrienol-rich fraction of palm oil
suggest that it may offer protection against myocardial ischaemia-reperfusion
injury. However, these effects require further study with dietary
supplementation models.
Studies with red palm oil (RPO), which contains the same components as refined
oil but also contains more micronutrients, confirm the above-described effects of
palm oil, enhanced by the presence of more micronutrients. It has also been shown
that dietary supplementation with RPO offers protection against myocardial
ischaemia-reperfusion injury. Again, however, further studies with RPO are
needed to fully confirm these effects on risk factors of ischaemia and cardiac
arrhythmias.
In conclusion, palm oil has shown only a mild effect on the lipid profile, and so
there is no saying whether its consumption would have any beneficial effect in
persons at cardiovascular risk (CVR). Nonetheless, it could be useful for some
people to consume this oil, since it is one of the few oils to have demonstrated
protective effect against myocardial ischaemia-reperfusion injury.
Teng et al.
[79]
Single-blind randomized crossover trial (n = 10 healthy males)
comparing the effects of high intake of fat (50 g) rich in palmitic acid of
both plant (palm olein) and animal (pork lard) origin versus
consumption of a fat rich in oleic acid (virgin olive oil) on lipaemia,
plasma glucose, insulin and adipocytokines.
The serum triglyceride (TG) concentration was significantly lower after
consumption of pork lard than after consumption of olive oil or palm olein (meal
effect p = 0.003; time effect p < 0.001). There was also a greater reduction in plasma
levels of non-esterified free fatty acids (FFA) in the group that consumed pork lard
than in the group that consumed olive oil (p < 0.05). The differences in the physical
and structural characteristics of pork lard TGs may account to some extent for the
fact that the increase of postprandial lipaemia was smaller than in the case of palm
olein. The effects of palm olein and olive oil on postprandial lipaemia were similar.
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Reference Type of Study and Aims Results and Conclusions
Levels of plasma glucose, insulin and adipocytokines [interleukin-6 (IL-6), tumoral
necrosis factor-α (TNF-α), interleukine-1β (IL-1β) and leptin] were unaffected by
the type of fat consumed. In the case of plasma IL-1β, there was such a change
over time after taking 3 meals with a high-fat diet (p = 0.036). These results could
suggest that it is a high fat intake, rather than the type of fatty acid (FA), that affects
the response of pro-inflammatory markers.
Fattore and
Fanelli [80]
Review of the scientific evidence on the relationship between palm oil
and adverse health effects.
The main reason why consumption of palm oil is associated with adverse health
effects is that it contains relatively high concentrations of saturated fatty acids
(SFAs), particularly palmitic acid, which in turn have been associated with
increased risk of coronary heart disease (CHD) and some types of tumor. However,
recent research on the subject has reconsidered the negative role of dietary SFAs as
a CVR factor and has shown that not only the type of fat but also the structure of
the TGs plays an important part in cholesterolaemia.
Some studies have concluded that modification of the type of fat, or modification
combined with reduction (but not only reduction) appear to reduce the incidence of
cardiovascular events in high-risk subjects. Moreover, most studies posit a possible
protective effect from partial replacement of SFAs by polyunsaturated (PUFAs) as
opposed to the adverse effect of SFAs per se. This is indicative of the importance of
continuing research to improve the balance between SFAs and PUFAs in foods.
The process of interesterification, which causes a reordering of palmitic acid and
does not occur naturally in native oil, could be associated with potentially adverse
health effects and hence is to be discouraged.
As for its role in the development of cancer, the studies are few and the evidence
unconvincing.
Despite these uncertainties, this review does not demonstrate a negative role of
palmitic acid in health, and much less native palm oil, which is a complex
alimentary matrix in which palmitic acid is only one of the components. Palm oil
also contains other FAs, chiefly oleic acid, along with antioxidant compounds,
which may have compensatory effects.
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Fattore et al.
[52]
Systematic review and meta-analysis of dietary intervention assays, to
evaluate the effect on lipid markers for CHD and cardiovascular disease
(CVD) of replacing palm oil with other primary dietary fats. The review
includes a total of 51 intervention studies ranging in duration from 2 to
16 weeks, in which palm oil-rich diets were compared with diets rich in
other fats, and in which at least one or more of the following CHD or
CVD biomarkers were determined: total cholesterol (TC), cholesterol
transported by low density lipoproteins (LDLc), cholesterol transported
by high density lipoproteins (HDLc), TC/HDLc ratio, TG,
apolipoprotein (Apo) A-I and Apo B.
Levels of TC, LDLc, Apo B, HDLc and Apo A-I were significantly higher in palm
oil-rich diets than in diets rich in stearic acid, monounsaturated fatty acids
(MUFAS) and PUFAs whereas most of these biomarkers were significantly lower
than in diets rich in myristic and lauric acids.
Comparison of the effect of palm oil-rich diets with diets rich in trans-FAs showed
that HDLc and Apo-A-I concentrations were significantly higher, while Apo B, and
TG concentrations and TC/HDLc ratio were lower.
This meta-analysis indicates that replacement of palm oil by other fats (SFAs,
MUFAs, PUFAs) produces both favorable and unfavorable changes in biomarkers
for CVD and CHD. However, when palm oil was replaced by trans-FAs, only
favorable changes were found.
The results do not support an association between palm oil replacement and
reduction of mortality from CVD. They rather suggest a need for fresh comparative
research and also call for caution in the development of policies for the general
population that promote the use of some specific fats over others. More solid
evidence is required as to the effects of palm oil on health and on the
socio-economic consequences before embarking on such policies.
Voon et al.
[81]
Randomized crossover trial of 5 weeks with a total of 45 volunteers. To
assess the effects of a (typical Malaysian) diet containing a high
proportion of protein and supplemented with virgin olive oil, palm
olein or coconut oil on arteriosclerosis markers (cell adhesion molecules,
lipid inflammatory mediators and thrombogenicity indices) in healthy
adults.
SFA-enriched diets (palm olein and coconut oil), and also a diet with virgin olive
oil, containing high levels of oleic acid, have similar effects on arteriosclerosis
markers, such as cell adhesion molecules and prostaglandin E2 (PGE2) and
thromboxane B2 (TXB2)/Prostaglandin F1α (PGF1α) thrombogenicity indices.
Only the diet supplemented with virgin olive oil exhibited a lower level of the
leukotriene B4 (LTB4) pro-inflammatory marker than the other two diets assayed.
The results indicate that it could be premature labelling palm olein and coconut oil
as “bad oils” because of their contribution to increased CVR based solely on their
effects on the serum lipid profile.
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Odia et al.
[82]
Review of experimental studies in animals and humans on the
association between palm oil and its constituents and serum lipid
profile and CVD.
Many scientific studies, both in animals and human beings, clearly show that
consumption of palm oil does not cause a rise in serum TC levels and that it is not
atherogenic. Apart from palmitic acid, palm oil is composed of oleic and linoleic
acids and also contains vitamins A and E, which are powerful antioxidants. It has
been demonstrated scientifically that palm oil protects the heart and blood vessels
from plaque and ischaemic lesions.
Consumed as part of a healthy, balanced diet, it does not cause increased CVR.
Replacing this oil with others rich in MUFAs and PUFAs would not produce any
additional benefit.
This review concludes that more longitudinal studies are required to assess the
impact on CVR of diets containing palm oil in comparison with diets containing
other oils accepted as “beneficial for cardiovascular health”, such as olive oil,
analyzing lipid parameters as risk markers.
Imoisi et al.
[83]
Review on palm oil: composition and health implications.
Prospective epidemiological studies have shown that the level of plasma TGs,
especially after eating, is a major factor in the pathogenesis of CHD. Palm oil is
considered as to raise TC and to increase the CVR because of its SFA content (44%
palmitic acid and 5% stearic acid). However, there is a growing body of scientific
evidence indicating that the effect of palm oil on TC is relatively neutral compared
to other fats and oils. Palm oil raises TC only when an excess of dietary cholesterol
is present in the diet.
Palm oil stimulates the synthesis of HDLc and the elimination of LDLc.
Palm oil is rich in vitamin E (particularly tocotrienols), which can reduce serum TC
concentrations and has powerful antioxidant effects. These benefits occur
especially from non-oxidized palm oil. Oxidized palm oil can have an adverse
effect on lipid profile, FFAs and phospholipids.
In conclusion, consumption of palm oil as a fat source in the diet does not pose any
additional risk of CHD when consumed in realistic quantities as part of a healthy
diet. Consumption of oxidized palm oil should be avoided owing to its adverse
effects on lipid profiles.
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Mancini et al.
[84]
Review on the functional role of palm oil and palmitic acid in the
development of obesity, type 2 diabetes mellitus, CVD, and cancer.
It also discusses the atherogenic potential of palmitic acid and its
stereospecific position in TGs.
As to the possible effects of palm oil-rich diets on CVR in humans, the studies
reviewed here report conflicting results. The main criticisms of these may be
summarized as follows: (a) considerable qualitative and quantitative heterogeneity
of FA concentrations in the diets; (b) differences in selection criteria used to form
the trial and control groups; (c) wide age range addressed in the studies; and (d)
little attention is paid to other dietary components which could confound the
direct effects of FAs on blood lipid markers.
To date no clear evidence has been found to demonstrate beyond a doubt the
association of consumption of palm oil with increased CVR, particularly in
normo-cholesterolaemic subjects, assuming the recommended intake of PUFAs.
Moreover, the percentage of palmitic acid at position sn-2 on the TG is smaller in
palm oil than in animal fats, which supports the hypothesis that palm oil has little
atherogenic potential in the context of a balanced diet, and that the alleged adverse
effects may be due to a dose-response ratio.
This review posit the need to carry out more rigorous research to define the
advantages and disadvantages of palm oil consumption as regards CVR.
Sun et al.
[60].
Systematic review on the effect of palm oil consumption on blood lipids
compared with other cooking oils, based on data from clinical trials
(minimum duration 2 weeks, comparing the effects of palm oil
consumption with that of other oils such as; low-SFA vegetable oils,
partially hydrogenated vegetable oils containing trans-FAs and animal
fats).
Palm oil significantly increased LDLc by 0.24 mmol/L (95% CI: 0.13, 0.35 mmol/L;
I(2) = 83.2%) compared with other low-SFA vegetable oils. This effect was
observed in randomized but not in non-randomized trials. Moreover, among
randomized trials, only modest differences in study results were observed
regarding the effects of palm oil versus LDLc. SFAs from palm oil appear to have
the same effects on LDLc as animal fat.
Palm oil increased HDLc by 0.02 mmol/L compared with the low-SFA vegetable
oils, and by 0.09 mmol/L compared with oils containing trans-FAs.
In conclusion, the consumption of palm oil results in a higher level of LDLc than
that of low-SFA vegetable oils, and in a higher level of HDLc if compared with the
effect of oils containing trans-SFAs. This would tend to support the
recommendation to reduce the use of palm oil and replace it with low-SFA and
trans-FA vegetable oils.
In the case of foods that are consumed in small quantities which are made using
trans-FAs for their sensory characteristics, palm oil can be an alternative thanks to
its better effects on HDLc.
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Marangoni
et al. [3]
Summary of the symposium‘s conclusions on the use of palm oil in
the food industry, produced by experts from several Italian medical
and nutritional scientific societies and collected by the nutrition
foundation of Italy. Toxicological and environmental issues were not
considered.
The main conclusions of the Symposium may be summarized thus:
(a) There is no evidence on the specific health effects of palm oil consumption as
compared with other SFA-rich fats.
(b) The stereospecific distribution of SFAs in the TG molecules of palm oil limits
their rate of absorption and their metabolic effects.
(c) International guidelines indicate that SFA intake should be less than 10% of
total energy, within a balanced diet. Within these limits, there is no reason to
expect palm oil consumption to have any effect on human health (and
especially on CVD or cancer risk).
Palm oil intake does not appear to be a public health priority in Italy, in light of its
overall effects and available consumption data.
Apo, apolipoprotein; CHD, coronary heart disease; CVD, cardiovascular disease; CVR, cardiovascular risk; FAs, fatty acids; FFAs, free fatty acids; HDLc, cholesterol transported by high
density lipoproteins; IL, interleukin; LDLc, cholesterol transported by low density lipoproteins; MUFAs, monounsaturated fatty acids; PUFAs, polyunsaturated fatty acids; RPO, red palm
oil; SFAs, saturated fatty acids; TC, total cholesterol; TG, triglyceride.
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Palm Oil and Microbiota
It is well known that the consumption of dietary fiber and the variety of the same is the factor that
most influences the quality of the intestinal microbiota, but until recently the impact of dietary fats on
it was unknown. Research such as that of Kübeck et al., or Just et al., have begun to shed some light on
the matter in animal models [85,86].
The research results of Just et al., indicate that the intestinal microbiota modulates the lipid
profile, and that the impact of dietary fat, whether of plant or animal origin, on the lipid profile
depends on the microbiota. At the same time, dietary fat modulates the microbiota present in mice,
so that the microbiota of mice which followed a low-fat diet were dominated by two lactic species,
producing short-chain (acetate, propionate, butyrate, and isovalerate) FAs, while high-fat diets altered
the metabolic capacity of amino acids, as well as the functional capacity of the microbiota. Mice fed
with a fatty diet of palm fat were the ones that developed a greater number of peptide similar to
glucagon-1 (GLP-1) enteroendocrine cells, which could account for better glucose tolerance in these
animals [86].
6. Palm Oil in Animal Nutrition
Diet is a determining factor in the composition of products obtained from monogastric animals
(birds and pigs). On the other hand, in ruminants (bovine, ovine and caprine), dietary fats are not
directly reflected in the composition of the fat of the animal, since the ruminant incorporates the
products of the transformation of the fat in the rumen. The digestive cavity in ruminants is divided
into four compartments: reticle, rumen, omasum, and abomasum (in this order in the cranial–caudal
direction). The conditions there—anaerobiosis, aqueous medium, high temperature, and a wide
presence of microorganisms (bacteria, protozoa, and fungi)—cause it to act like a fermentation chamber.
The main energy ingredients in feed for ruminants are cereals, followed by vegetable oils (palm,
soy, and sunflower), animal fats (lard and tallow) and industrial greases (inert greases such as soaps
and hydrogenated palm oil and oleins). In suitable proportions, these fats and oils improve the energy
density of their diets. However, vegetable oils containing a high concentration of UFAs, interfere in the
progress of ruminal fermentations, inhibiting microbial activity. Therefore, ruminants hydrogenate fats
to protect themselves from the negative effects that UFAs have on them, thus engendering the natural
trans-FAs present in products from ruminants.
Thus, while in compound feed intended for monogastric animals, the type of fat used is unsaturated
or a combination of saturated and unsaturated (e.g., high oleic sunflower for Iberian pork fat and
butter or soy for birds), in food for ruminants saturated fat is preferable. Consequently, of the vegetable
oils available in the marketplace, palm oil is the one most used in ruminant diets. This is because it
contains more SFAs and hence has less of an adverse effect on ruminal microbiota, and a much more
competitive and stable price on the commodity market than other vegetable oils.
In 2017, in the EU-28 159 Mt of compound feed was produced for livestock, where the addition of
ingredients such as oils and fats accounted for 2% of output [87]. In 2017, more than 35 Mt of feedstuffs,
of which nearly 10 Mt were for ruminant animals, were manufactured in Spain [88].
Consumers nowadays demand good quality products at a low cost. The production of meat
products to meet demand requires compound feed to ensure food safety and a balance in the price of
the final product. In the current food composition tables, compared to 30 years ago, the fat content of
foods of animal origin has decreased a lot (around 15%). Meat, other than offal, contains 4%–5% of
fat [50].
7. The Use of Palm Oil in the Food Industry
To contextualize palm oil and its use in the food industry we must briefly analyze the evolution in
the use of SFAs by the industry. Thanks to their consistency, SFA-rich fats provide the appropriate
texture for a series of foods both in traditional domestic use and in the industry. These textures are not
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achieved with less SFA-rich oils or fats. Traditionally, animal fats were used for their palatability and
experience in consumer tastes. As scientific studies indicated that animal fats with higher SFA contents
are responsible for CVD, these were replaced by hydrogenated vegetable oils (also solids), offering
great versatility in terms of textures, with a consistency similar to animal fats and containing trans- FAs.
In the 1990s, the first lipid profile studies on the effect of trans-FA consumption revealed the negative
effect of this type of fat on lipid biomarkers and the CVR associated with its consumption [6]. Initially,
the labelling of such products was regulated, making it obligatory to distinguish between oil and fat,
animal and vegetable, as well as totally or partially hydrogenated fats, so that the consumer ended up
associating the word “hydrogenated” with “trans” and with unhealthy. Scientific evidence has now
prompted regularization, with prohibition of the use of “trans” in some European countries such as
Denmark, the Netherlands and the USA. Vegetable fats and oils have replaced the use of trans-FA-rich
hydrogenated fats almost entirely in the European industry. The Spanish Food Safety and Nutrition
Act deals with trans-FAs, stating that “in industrial processes in which trans-FAs can be generated, the
responsible operators will establish adequate conditions to minimize the formation of these where they
are intended for food, either as such or as a food component. In addition, they will ask their suppliers
for information on the trans-FA content of the food or raw materials they provide and will have at
their disposal the information related to the FA content in their products. These requirements will not
apply to products of animal origin that naturally contain trans-FAs”. As indicated in the introduction
of this document, both the WHO and scientific societies recommend that the intake of trans-FAs be less
than 1% of the total daily energy intake [89]. In 2015, the European Commission issued a report urging
that trans-FA content be reduced as much as possible [90]. EU Regulation 2019/649 specifies that the
content of trans fats, in foods intended for the final consumer and supply to retailers, should not exceed
2 g per 100 g of fat, provided that trans fats are not naturally present in fats of animal origin [91]. Thus,
the Commission responded to resolution 2016/2637 in which the European Parliament requested the
establishment of a legal trans-FA limit for the entire EU [92].
7.1. Justification for the Inclusion of Palm Oil in the Composition of Processed Foods
Palm oil is used for various purposes in the food industry: Frying, margarines (puff pastries,
croissants), toppings and fillings, and others (premixes, emulsifiers). Among the technological
characteristics that it contributes is a melting point close to 37 ◦C, guaranteeing a product with some
solidity that melts on the palate when consumed, producing an effect that is not achieved with any
other oil. In addition to its palatability and structure, the great stability of this oil in the frying process
obviates the need to use antioxidant food additives. Another outstanding factor is the versatility of
palm oil, in that different fractions can be mixed to achieve different strengths and textures, such as
croissants and puff pastries, unattainable with other oils or fats. If we take ice creams as an example, at
first these were made with milk fat. Little by little this was replaced by coconut fat, which a few years
later was replaced by palm fat, whose price was more competitive. In recent years, some manufacturers
have been turning to coconut fat because the use of palm oil is being questioned. It should be noted
that coconut oil has a more atherogenic FA profile than palm oil, mainly due to its high content of
medium chain SFAs (lauric and myristic). Other candidates to replace palm oil in the industry include:
shea butter, with an annual production of 400,000 tons (75% for internal consumption in the countries
of origin); cocoa butter, production of which reaches 1 Mt per year; butter, with very low availability;
and hydrogenated seed oils. None present technological advantages comparable to palm oil, and
all are much more expensive. European Regulation 1169/2011 on food information provided to the
consumer establishes that both vegetable oils and refined vegetable fats, if they have been subjected to
hydrogenation processes, must be labelled as “totally hydrogenated”, or “partially hydrogenated”, as
the case may be, guaranteeing less than 1% of trans-FAs [93]. Up to 60 Mt of palm oil is produced
per year, and hence it maintains a lower and more stable price in the vegetable fat market. All the
above-mentioned candidates to replace palm oil (cocoa, shea butter, butter) suffer from high price
volatility and low availability, which encourages the industry to lean towards palm oil.
Nutrients 2019, 11, 2008 23 of 36
Although of potential interest from a nutritional point of view because of its high tocotrienol
content, the use of red (crude) palm oil is ruled out because of its variability, acidity, color, and the
flavor that it would impart to the food product, altering the consumer’s perception of palatability.
The Spanish quality standard for heated oils and fats establishes a maximum of 20%–25% polar
compounds in frying oils [94]. Palm oil leaves 8% of these compounds in the form of diglycerides
(DG), but as it is more stable due to its high SFA content, it takes longer to reach the limit values.
Studies by the Sánchez-Muniz group with the palm olein fraction have demonstrated the enormous
stability of this oil in repeated potato fries, even when the oil is not renewed [95]. However, given
its high DG content palm olein may not be suitable for frying certain foods. But at the same time
there is a perceived need for the food industry to find a balance between the negative aspects for
cardiovascular health derived from the SFA component and the positive aspects of consumption of low
levels of oxidized and polymerized FAs [96]. The health effects of altered FA consumption described
so far derive from studies in which alteration components were isolated in high doses or from studies
with highly altered oils and remote from daily consumption rates. Frying temperatures above 200 ◦C
considerably promote the dimerization and polymerization of TGs. Dimers and polymers are the most
toxic compounds, although they tend to be less absorbed. The results suggest that the consumption of
altered oils with high concentrations of free radicals and polymerization compounds could raise the
CVR and susceptibility to damage in membrane lipoproteins and affectations of the hepatic microsomal
system via CYP4A1 and the regulation of genes dependent on the transcription factor PPAR-alpha [97,98]
for although they are partially neutralized, they are absorbed and metabolized [96,97]. These authors
have indicated that intake of highly thermo-oxidized oils reduces intestinal antioxidant defense in
rats, modifying the gene expression of antioxidant enzymes, and the damage is greater when the oils
are consumed after a 15-hour fast period [99]. However, again we must insist that much information
relating to altered oils and toxicity derives from the study of oils subjected to excessive heating (not oils
used in frying) and that the frying of food can be considered a safe technique when the oils are used
for limited periods of time, correctly, at controlled temperatures, and under regulated oil renewal
conditions [97,98].
7.2. Role of Industry in Sustainable Palm Oil
As already mentioned above, solid fats at room temperature and with a certain degree of hardness,
such as butter, margarine, and frying oils, are essential in the preparation of some foods. Until the
producing companies opted for the non-use of partially hydrogenated oils, palm oil was a component
in the fats prepared for the food industry. Since then the use of palm oil has increased, either as such
(100% palm), or mixing something harder with palm fractions. Some producers also occasionally
use interesterification with mixtures of other oils to achieve a smoother solids curve and reduce the
difference between the solid and the liquid phases. Currently, palm oil in its various forms is therefore
the only economically viable alternative for use in certain applications as a substitute for trans-FAs.
As a result, distribution requirements have turned on food security (minimization of the presence
of chemical contaminants, technological aspects), and on sustainability (mainly in RSPO certification),
initially in the MB form and a second stage, in the SG form, which entails a great deal of control and
traceability of the distribution chain. The advantage of the RSPO certification is that the consumer can
read the guarantee of sustainability on the label.
As already mentioned above, one of the qualities of palm in frying oil is its high stability. This
means that in fryers operating continuously with a rate of renewal (turn-over) less than 10 h, there is
no need to change the oil, only to replace the quantity absorbed by the food. Apart from oxidation
stability, palm oil brings structure to the product, in such a way that when it cools to room temperature,
the solid fraction provides consistency and maintains a palatable mouthfeel, avoiding the typical oily
texture of products fried in vegetable oils that are liquid at room temperature.
Figure 4 shows the technological difficulties and the economic cost of replacing palm oil with other
fats. Palm oil is also used for the manufacture of emulsifiers; whose emulsifying capacity depends
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on its FA stereo configuration. For some specific applications, such as delaying aging of bread, it is
important that the FA has linear configuration, as in the SFA.
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8. Food Safety and Toxicologi al Aspects
Doubts have been raised about the safety of palm oil by the finding that it may contain
3-monochloropropane-1, 2-diol (3-MCPD), 2-monochloropropane-1, 2-diol (2-MCPD), glycidol and its
glycidyl esters (GE), and that their presence can be detected in many foods containing pal oil [100,101].
In 2016, two scientific committees responsible for risk assessment, the JECFA (Joint FAO/WHO Expert
Committees on Food Additives), and the FAO/WHO and EFSA-CONTAM-dependent (Panel of
Contaminants in the Food Chain), issued two separate scientific opinions regarding toxic contaminants
in palm oil and other vegetable oils which are generated in the process of refining (GE, 2-MCPD,
3-MCPD) [102,103]. Both com ittees carried out an evaluation of the exposure of the population to
these substances through national consumption surveys, and both concluded that younger populations
are most exposed. According to the EFSA and the JECFA, the main sources of exposure to 2-MCPD,
3-MCPD, and GE in the population aged 3 or over are margarine, pastry, and cakes, albeit there may
be variations depending on the oil source. After analyzing the different available toxicological tests,
each established recommendations for exposure to these contaminants once a health-based guide
was established (Health Based Guidance Value—HBGV) for 3-MCPD and the acceptable margin of
exposure (MoE) to glycidyl. Table 6 shows the average contents of these contaminants in different oils.
Table 6. 3-MCPD and glycidil ester (GE) levels in different oils and fats
Mean
Content
(mg/kg)
(2009)
Maximum
Content
(mg/kg)
(2009)
Mean
Content
(ppm) (2011)
Maximum
Cont
(ppm) (2011)
Mean
Content
(mg/kg)
(2019)
Maximum
Content
(mg/kg)
(2019)
Canola oil 0.3 1.5 1 1 1.03 (*) N
Soya oil N N 0.5 0.6 N N
Sunflower oil 1 5.7 2 4 1.82 2.05
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Mean
Content
(mg/kg)
(2009)
Maximum
Content
(mg/kg)
(2009)
Mean
Content
(ppm) (2011)
Maximum
Content
(ppm) (2011)
Mean
Content
(mg/kg)
(2019)
Maximum
Content
(mg/kg)
(2019)
Corn oil 2.8 7 7 9 0.9 1.55
Coconut oil N N 7 7.5 Nd Nd
Palm oil 4.5 13 6 14 6.22 (*) N
Sesame oil N N N N 1.6 1.63
Safflower oil N N N N 2.78 (*) N
Extra virgin olive oil N N N N Nd Nd
Refined olive oil 1◦ N N N N 0.78 1.11
Refined olive oil 0.4◦ N N N N 0.95 1.22
Fried extra virgin
olive oil N N N N 0.93 1.72
Prepared by authors, based on Mathäus et al., 2011 [104]; Willits, 2013 [105]; and Custodio-Mendoza et al., 2019 [106];
N: non- determined; Nd: Non detectable; (*) Data from a single oil sample.
There are various different stages in the assessment of contaminant risk: (1) hazard identification
(identifying the adverse effects on health, the target organ and critical toxicological effect (end point) of
the target contaminants); (2) characterization: danger (aimed at deriving a HBGV, for example the
tolerable daily intake (TDI) from one point of reference obtained from toxicological studies); (3) exposure
assessment (takes into account food consumption and the emergence of chemical contaminants in food
by food groups, groups of population, in acute vs. chronic exposure); and (4) risk characterization
(takes into account exposure to the contaminant vs. HBGV, in this case the TDI—this is considered the
intake level that poses no appreciable risk for health). The TDI provides a HBGV for chronic exposures
or long-term contaminants in foods and is often established from a starting point (P0D), for example, a
NOAEL (no observed adverse effect level) identified from toxicological tests to doses in experimental
animals. This TDI is then compared with chronic dietary exposure.
For characterization of the hazard information, the critical toxicological points obtained from the
studies conducted in laboratory animals or rarely in humans need to be established. This information
will be taken for the identification of a NOAEL or similar, such as the BMDL10, (benchmark dose level)
and thus establish a TDI.
The analysis of the “reference dose” (benchmark dose BMD) uses the average of the model
resulting in the “reference dose level” (BMDL10); the value produced by the study is the critical point
that is associated with an additional risk of 10% of the adverse effects on experimental animals exposed.
8.1. Definition, Formation, and Possibility of Reduction of the Contaminants Free and Esterified 2-MCPD and
3-MCPD and Glycidil Esters (GE).
These contaminants appear during the refining phase of vegetable oils, such as olive, sunflower,
and palm, entailing high temperatures, especially at the deodorization stage.
The 3-MCPDs are formed in the refining of oils as well as during processing or preparation
of food when exposed to high temperatures (>230 ◦C) in the presence of chlorine, resulting in the
formation of HCl reagent. This chlorine may originate in: (a) inorganic chlorine present in fertilizers
(NH4Cl, KCl) and flocculants used in treatment of wastewater (FeCl3); (b) organochlorine products
generated endogenously by the oil palm; (c) chlorinated molecules which accumulate in the fruits of
the palm during its growth; or day) thermal degradation causing the formation of HCl reagent during
refining. Washing fresh fruit with water clusters has been found to remove 95% of the chlorinated
Nutrients 2019, 11, 2008 26 of 36
substances [105]. Regarding 2-MCPDs, there is too little available information to be able to judge, and
it is extrapolated from what is known of the 3-MCPD.
GEs are found only in oils and refined vegetable fats. They arise when high temperatures are
reached in the oil deodorization process (>200 ◦C according to the EFSA [107], >240 ◦C according to
the JECFA [102]), and from the transformation that occurs from the diacylglycerol, without the need
of HCl.
In these contaminants, free forms are more active in vivo than esterified forms. The conversion
from ester form to free form occurs through hydrolysis; complete hydrolysis is assumed in vivo and is
considered also to occur in neonates.
These contaminants from processed vegetable oils have been found in greater quantity in palm
oil/fat. Wong et al., have studied the formation of GEs and 3-MCPDEs in potato crisps with RBD
palm olein (refined, bleached and deodorized) in a deep fryer. To this end, they analyzed the oil
after frying potatoes at different temperatures (160 ◦C or 180 ◦C) with added salt (0%, 1%, 3%, and
5%) for 100 min/day over 5 consecutive days. These researchers conclude that the duration of the
frying, the temperature and the concentration of salt, all play significant parts in formation of the
toxic contaminant compounds referred to here. The order of the effects was: temperature > time >
salt. In general, the tendency was for 3-MCPDEs to decrease with longer frying, and to increase with
increasing temperature and salt concentration. The trend for GEs was to increase with the increasing
of all three parameters in the study. Evaluation of the quality of the oil showed that this did not exceed
the safety limits (conjugated p-anisidine, FFA, dienes and trienes), but the authors did point out the
need to control the frying time and temperature, as well as the addition of salt, to foods cooked in this
way [108].
Most palm oil products found on the market come in RBD forms. Refining is necessary to eliminate
impurities and contaminants that affect the quality of the final product. However, it is important that
the refining process retain as many natural antioxidants as possible (tocopherols and tocotrienols),
in order to maintain the stability of the oil. Most crude palm oil is refined by physical processes,
although a small percentage is chemically refined. Some refinement stages are performed at high
temperatures (250–270 ◦C), which favor the formation of these toxic contaminants [109]. Other methods
have been developed which in addition to conserving carotenes, are performed at lower temperatures
(150–170 ◦C), thus greatly reducing the formation of contaminants [110].
Authors such as Willits propose measures to reduce the contaminants in oils, specifically in palm
oil. RBD palm oil may have less than 2 mg/kg of 3-MCPDE or GE, if: (a) the quality of palm oil is good
(low acyl-glycerol content and low chlorinated precursors; (b) natural bleaching soil is used (for low
3-MCPDE content); (c) deodorization is carried out at a temperature below 230 ◦C (for low GE content).
In addition, there are other refining options: (a) chemical refining, with the drawback that a soapy
paste can form as a lateral current; (b) physical semi-refining, in which the challenge is to have low
FFA levels and a light color; (c) In any case, the heat load during deodorization has to be low [105].
8.2. Risk Assessment of Contaminants
In 2013, in its preliminary assessment of the risk of the presence of 3-MCPDs in foodstuffs, the EFSA
estimated a mean exposure <1 µg/kg body weight/day (µg/kg bw/d), and concluded that the exposure
value for the majority of the population groups was lower than the TDI of 2 µg/kg bw/d [107]. However,
the publication of a second opinion in May 2016 modified these preliminary results in response to
data from a larger number of samples proposing a new, lower TDI value (0.8 µg/kg bw/d). The EFSA
calculated a level of exposure for 3-MCPDs and its esters exceeding the TDI in the population group
of infants and children [103]. Shortly after, in November 2016, the JECFA published the conclusions
of the current evaluation of 3-MCPDs and glycidol and its esters, setting a new provisional TDI of
4 µg/kg bw/d for the sum of 3-MCPD and esters [102], five-fold higher than the one established by
the EFSA in its second assessment. Due to the large difference between the toxicological reference
values proposed by the two scientific committees, the EFSA decided to review its scientific opinion
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of 2016 once again. This review of the evaluation of the risk of 3-MCPD and esters was published in
2018, setting the TDI at 2 µg/kg bw/d, the same as in its first assessment of 2013 [111]. The differences
in the TDI values set by the FAO/WHO and the EFSA make it difficult to arrive at a conclusion on
the TDI derived from the presence of chemical contaminants generated during refining. There is
clearly a real possibility that exposure in the most sensitive population group (infants) exceeds the
set TDI value, so a study of new technological strategies to reduce or prevent the formation of these
contaminants is justified. However, it should be considered that the exposure time is very limited
in this population, since the WHO recommends exclusive breastfeeding up to the first 6 months of
life, when the inclusion of other foods begins. On the other hand, although other exposed population
groups or groups that exceed the TDI values according to the estimates of exposure in the EFSA and
JECFA reports, are children between 2 and 10 years, the data of real intake derived from ANIBES or
ENALIA studies performed in Spain show a low intake of the food groups containing higher amounts
of these contaminants [42,112,113].
In the EU, the maximum levels of various contaminants in foods (nitrates, mycotoxins, metals
and 3-MCPDs, dioxin, PCBs, PAH, melamine, etc.) are governed by Regulation 1881/2006 [114]. This
in turn is amended by Regulation (EU) 2018/290, which additionally provides maximum levels of GEs
in oils and vegetable fats as well as follow-on milks and infant milks. Maximum 3-MCPD levels are
only set for hydrolyzed vegetable protein and soy sauce [115]. Currently, the Commission’s working
groups are discussing new values for 3-MCPDs and their esters in fats and vegetable oils, including oil
palm, which will probably be approved during 2019. Table 7 shows the maximum levels of 3-MCPDs
and GEs laid down by Regulation 2018/290.
Table 7. Maximum levels of 3-MCPD and GE (Regulation 2018/290) [115].
Foodstuffs Maximum Level (µg/kg)
4.1 3-Monochloropropanediol (3-MCPD)
4.1.1 Hydrolysed vegetable protein 20
4.1.2 Soy sauce 20
4.2 Glycidyl Fatty Acid Esters Expressed as Glycidol
4.2.1
Vegetable oils and fats placed on the market for the final consumer
or for use as an ingredient in food with the exception of the foods
referred to in 4.2.2
1000
4.2.2 Vegetable oils and fats destined for the production of baby foodand processed cereal-based food for infant and young children 500
4.2.3 Infant formula, follow-on formula and foods for special medicalpurposes intended for infants and young children (powder)
75 until 30 June 2019.
50 as from 1 July 2019
4.2.4 Infant formula, follow-on formula and foods for special medicalpurposes intended for infants and young children (liquid)
10.0 until 30 June 2019.
6.0 as from 1 July 2019
8.3. Palm Oil and Risk of Cancer
Some social alarm regarding palm oil and cancer risk has been prompted by two different issues.
On the one hand, the International Agency for Research on Cancer (IARC) has classified 3-MCPD as a
possible carcinogen (group 2B) and glycidol and its esters as probable carcinogens (Group 2A), while
2-MCPD has not been evaluated by this WHO-dependent agency to date [116–118]. Qualification
as a potential carcinogen by the WHO should not be associated with the existence of a real risk,
because we have to distinguish between hazard and risk. The WHO says ‘danger’, but proper and
transparent “case by case” risk assessment is needed to conclude that there is actually such a hazard.
The health effects of these technologically-generated chemical contaminants are still the subject of
discussion [100,118–120].
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Then again, in 2017 Pascual et al., published a study showing that palmitic acid, or a high-fat diet,
can facilitate certain metastasis mechanisms through expression of the CD36 (Cluster of differentiation
36) receptor [57]. Since then, attention has been focused on palmitic acid, and by association on palm
oil. It is important to clarify that palmitic acid is not a toxic substance, as the authors have stated. Note
that this is an in-vitro mechanistic study on expression of a receptor cell in tumor tissue with very
high, not physiological, dose. This type of studies cannot be extrapolated to the amount of dietary FAs
available for cells in-vivo.
Currently, there is no scientific evidence on the relationship between palm oil intake and the
occurrence of cancer. According to the conclusions of the “Symposium of the Italian Foundation
of Nutrition on palm oil and health” held in Milan from 3 May 2016, there is no experimental or
epidemiological evidence to warrant associating the consumption of palm oil with a higher incidence
of cancer mortality in human beings, and the indirect evidence suggests that palm oil has no positive
or negative effects on the risk of cancer [3].
9. Palm Oil as an Example of the Complexity of Communication in Nutrition
Nutrition is a complex science, since it includes genetic, metabolic, biochemical and other aspects,
as explained throughout this consensus document. In trying to convey this knowledge to the population,
the media tend to simplify, omitting important details, which ultimately leads to disinformation or
misinformation and even unfounded alarms. This problem is magnified nowadays by the ease of
dissemination and access to information through social networks.
In fact, due to the controversy that has arisen regarding the safety of palm oil, the Committee
on Nutrition of the Spanish Paediatrics Association (AEP) and the Spanish Society of Paediatric
Gastroenterology, Hepatology, and Nutrition (SEGNP) issued a statement regarding the inclusion of
palm oil and palmitic acid in infant formula, indicating that the restriction of fat intake, recommended
as a general measure for improving the health of the general population, should not apply to infants
and young children, and also that the incorporation of palmitate to infant formulas is necessary to
ensure that the composition is as similar as possible to the composition of breast milk [121].
In order to analyze the perception of European consumers in relation to “no” or “free” labels on
foods and beverages, the European Food Information Council (EUFIC) conducted a survey in 2017,
where the three main aspects considered were the nutritional value of the product, environmental
concerns and the safety of food for consumption. It was noted that consumers in countries such as the
United Kingdom, France, or Sweden associated the term “palm oil” with environmental and ethical
issues such as the destruction of the natural environment and the plight of orangutans; while in Poland
it was associated with “healthier”. When analyzing consumer attitudes to labelling, it was noted
that in France the preference was for products labelled “palm oil-free” as healthier, whereas in other
countries there were no differences in this aspect of labelling. It is worth noting that of the countries
surveyed, France is the one where the presence of products labelled “palm oil-free” is greatest.
Another aspect that can contribute to the confusion is when new knowledge arises in nutrition
which questions or qualifies existing recommendations [122–124]. For instance, there is some recent
meta-analysis that does not confirm an association between palm oil/SFA consumption and greater CVR
or mortality in general [53,54,123,125,126]. Some authors like Mensink et al., have actually pointed out
that SFAs also increase HDLc [127]. These new discoveries, which partly contradict previous results,
disturb and puzzle the consumer. Therefore, scientific communication in a truthful but accessible
language is fundamental.
10. Conclusions
10.1. Sustainability
1. In response to the environmental impact posed by the cultivation of oil palm, 15 years ago the
RSPO was founded, which certifies the sustainability of palm oil production.
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2. The “Amsterdam Declaration” urges the inclusion of sustainability throughout the food
production chain. Several countries and organizations are signatories, among them the RSPO, which
made a commitment to the implementation of 100% sustainable palm oil in the European food chain
by 2020.
3. Thanks to the work done over the past years, palm oil is one of the agricultural products
leading sustainable production, although concerns about sustainability are evident also in various crops
globally. It is essential to educate the consumer on the importance of selecting sustainable products to
contribute to maintenance of the environment and local economies in the producing countries.
10.2. Nutrition
1. The review of the current scientific evidence on the safety of palm oil indicates that its
consumption in moderate amounts, and in the context of a varied, balanced and adequate diet, does
not present health risks.
2. Several more-or-less current studies are contributing to a reassessment of strongly implanted
dogmas about saturated fat and its relationship to cardiovascular health. If these recent studies
are confirmed, the association between consumption of SFAs and CVR could be modified or at
least qualified.
3. Currently there is not enough evidence to warrant modifying fat intake recommendations
regarding 20%–35% of total calories, nor the criterion that SFA intake should not exceed 10% of the
total energy intake, which means that this fat intake should be at most about 20 g/day within a 2000
kcal a day diet.
10.3. Industry
1. The food industry is among those most concerned to maintain a high level of product quality
and satisfy consumer demands. Among these demands as they relate to palm oil, apart from nutritional
aspects, there is increasing stress on food security, and to a lesser extent sustainability.
2. The fact is that the industry is already consuming sustainable palm oil, and the forecast is for
a gradual increase in the use of RSPO certified palm oil, refined using milder processes to achieve a
significant reduction in the presence of technologically-generated chemical contaminants.
3. The collaboration of universities, research and technological centers, and the media is essential
to assure the dissemination of objective, unbiased information.
10.4. Safety
1. For the present there is no scientific evidence (experimental or epidemiological) to warrant
associating palm oil consumption with a higher cancer incidence or mortality risk in humans.
2. Both the JECFA and the EFSA have established levels of TDI for toxic contaminants generated
in the processing of vegetable oils (3-MCPDs and GEs) at 4 µg/kg bw/d and 2 µg/kg bw/d respectively.
In light of these recommendations, the Commission has amended its regulation of contaminants
regarding GEs and is working on 3-MCPDs.
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